-
1
-
-
34249995115
-
Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis
-
Alvarez, C.A., Wiederhold, N.P., McConville, J.T., Peters, J.I., Najvar, L.K., Graybill, J.R., Coalson, J.J., Talbert, R.L., Burgess, D.S., Bocanegra, R., Johnston, K.P. & Williams, III, R.O. (2007) Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis. Journal of Infection, 55, 68-74.
-
(2007)
Journal of Infection
, vol.55
, pp. 68-74
-
-
Alvarez, C.A.1
Wiederhold, N.P.2
McConville, J.T.3
Peters, J.I.4
Najvar, L.K.5
Graybill, J.R.6
Coalson, J.J.7
Talbert, R.L.8
Burgess, D.S.9
Bocanegra, R.10
Johnston, K.P.11
Williams III, R.O.12
-
2
-
-
0036133373
-
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an International consensus
-
Ascioglu, S., Rex, J.H., de Pauw, B., Bennett, J.E., Bille, J., Crokaert, D., Denning, D.W., Donnelly, J.P., Edwards, J.E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J.F., Patterson, T.F., Ritter, J., Selleslag, D., Shah, P.M., Stevens, D.A. & Walsh, T.J. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an International consensus. Clinical Infectious Diseases, 34, 7-14.
-
(2002)
Clinical Infectious Diseases
, vol.34
, pp. 7-14
-
-
Ascioglu, S.1
Rex, J.H.2
de Pauw, B.3
Bennett, J.E.4
Bille, J.5
Crokaert, D.6
Denning, D.W.7
Donnelly, J.P.8
Edwards, J.E.9
Erjavec, Z.10
Fiere, D.11
Lortholary, O.12
Maertens, J.13
Meis, J.F.14
Patterson, T.F.15
Ritter, J.16
Selleslag, D.17
Shah, P.M.18
Stevens, D.A.19
Walsh, T.J.20
more..
-
3
-
-
58349122651
-
Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
-
Barnes, R.A., White, P.L., Bygrave, C., Evans, N., Healy, B. & Kell, J. (2009) Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. Journal of Clinical Pathology, 62, 64-69.
-
(2009)
Journal of Clinical Pathology
, vol.62
, pp. 64-69
-
-
Barnes, R.A.1
White, P.L.2
Bygrave, C.3
Evans, N.4
Healy, B.5
Kell, J.6
-
4
-
-
77955148951
-
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection
-
Ben-Ami, R., Lewis, R.E. & Kontoyiannis, D.P. (2010) Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. British Journal of Haematology, 150, 406-417.
-
(2010)
British Journal of Haematology
, vol.150
, pp. 406-417
-
-
Ben-Ami, R.1
Lewis, R.E.2
Kontoyiannis, D.P.3
-
5
-
-
0037096886
-
Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials
-
Bow, E.J., Laverdiere, M., Lussier, N., Rotstein, C., Cheang, M.S. & Ioannou, S. (2002) Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer, 94, 3230-3246.
-
(2002)
Cancer
, vol.94
, pp. 3230-3246
-
-
Bow, E.J.1
Laverdiere, M.2
Lussier, N.3
Rotstein, C.4
Cheang, M.S.5
Ioannou, S.6
-
6
-
-
0025117876
-
Management of fungal infection in neutropenic patients with fluconazole
-
Brammer, K.W. (1990) Management of fungal infection in neutropenic patients with fluconazole. Haematology & Blood Transfusion, 33, 546-550.
-
(1990)
Haematology & Blood Transfusion
, vol.33
, pp. 546-550
-
-
Brammer, K.W.1
-
7
-
-
65549159077
-
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents
-
Brüggemann, R.J.M., Alffenaar, J.-W., Blijlevens, N.M.A., Billaud, E.M., Kosterink, J.G.W., Verweij, P.E. & Burger, D.M. (2009) Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clinical Infectious Diseases, 48, 1441-1458.
-
(2009)
Clinical Infectious Diseases
, vol.48
, pp. 1441-1458
-
-
Brüggemann, R.J.M.1
Alffenaar, J.-W.2
Blijlevens, N.M.A.3
Billaud, E.M.4
Kosterink, J.G.W.5
Verweij, P.E.6
Burger, D.M.7
-
8
-
-
8744314133
-
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
-
van Burik, J.A., Ratanatharathorn, V., Stepan, D.E., Miller, C.B., Lipton, J.H. & Vesole, D.H. (2004) Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clinical Infectious Diseases, 39, 1407-1416.
-
(2004)
Clinical Infectious Diseases
, vol.39
, pp. 1407-1416
-
-
van Burik, J.A.1
Ratanatharathorn, V.2
Stepan, D.E.3
Miller, C.B.4
Lipton, J.H.5
Vesole, D.H.6
-
9
-
-
33644832215
-
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus
-
Chamilos, G. & Kontoyiannis, D.P. (2006) Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resistance Updates, 8, 344-358.
-
(2006)
Drug Resistance Updates
, vol.8
, pp. 344-358
-
-
Chamilos, G.1
Kontoyiannis, D.P.2
-
10
-
-
37549022969
-
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study
-
Cordonnier, C., Mohty, M., Faucher, C., Pautas, C., Robin, M., Vey, N., Monchecourt, F., Mahi, L. & Ribaud, P. (2008) Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study. International Journal of Antimicrobial Agents, 31, 135-141.
-
(2008)
International Journal of Antimicrobial Agents
, vol.31
, pp. 135-141
-
-
Cordonnier, C.1
Mohty, M.2
Faucher, C.3
Pautas, C.4
Robin, M.5
Vey, N.6
Monchecourt, F.7
Mahi, L.8
Ribaud, P.9
-
11
-
-
63649156819
-
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized controlled trial
-
Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suarez, F., Chedin, N., Isnard, F., Ades, L., Kuhnowski, F., Foulet, F., Kuentz, M., Maison, P., Bretagne, S. & Schwarzinger, M. (2009) Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized controlled trial. Clinical Infectious Diseases, 48, 1042-1051.
-
(2009)
Clinical Infectious Diseases
, vol.48
, pp. 1042-1051
-
-
Cordonnier, C.1
Pautas, C.2
Maury, S.3
Vekhoff, A.4
Farhat, H.5
Suarez, F.6
Chedin, N.7
Isnard, F.8
Ades, L.9
Kuhnowski, F.10
Foulet, F.11
Kuentz, M.12
Maison, P.13
Bretagne, S.14
Schwarzinger, M.15
-
12
-
-
77956489402
-
Voriconazole for secondary prophylaxis of invasive fungal infections in patients with allogeneic stem cell transplants (VOSIFI) study group
-
Cordonnier, C., Rovira, M., Maertens, J., Olavarria, E., Faucher, C., Bilger, K., Pigneux, A., Cornely, O.A., Ullmann, A.J., Bofarull, R.M., de la Camara, R., Weisser, M., Liakopoulou, E., Abecasis, M., Heussel, C. P., Pineau, M., Ljungman, P. & Einsele, H. (2010) Voriconazole for secondary prophylaxis of invasive fungal infections in patients with allogeneic stem cell transplants (VOSIFI) study group. Haematologica, 95, 1762-1768.
-
(2010)
Haematologica
, vol.95
, pp. 1762-1768
-
-
Cordonnier, C.1
Rovira, M.2
Maertens, J.3
Olavarria, E.4
Faucher, C.5
Bilger, K.6
Pigneux, A.7
Cornely, O.A.8
Ullmann, A.J.9
Bofarull, R.M.10
de la Camara, R.11
Weisser, M.12
Liakopoulou, E.13
Abecasis, M.14
Heussel, C.P.15
Pineau, M.16
Ljungman, P.17
Einsele, H.18
-
13
-
-
33846462456
-
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
-
Cornely, O.A., Maertens, J., Winston, D.J., Perfect, J., Ullmann, A.J., Walsh, T.J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., Petrini, M., Hardalo, C., Suresh, R. & Angulo-Gonzalez, D. (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. New England Journal of Medicine, 356, 348-359.
-
(2007)
New England Journal of Medicine
, vol.356
, pp. 348-359
-
-
Cornely, O.A.1
Maertens, J.2
Winston, D.J.3
Perfect, J.4
Ullmann, A.J.5
Walsh, T.J.6
Helfgott, D.7
Holowiecki, J.8
Stockelberg, D.9
Goh, Y.-T.10
Petrini, M.11
Hardalo, C.12
Suresh, R.13
Angulo-Gonzalez, D.14
-
14
-
-
58149234268
-
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies, Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
-
Cornely, O.A., Böhme, A., Buchheidt, D., Einsele, H., Heinz, W.J., Karthaus, M., Krause, S.W., Krüger, W., Maschmeyer, G., Penack, O., Ritter, J., Ruhnke, M., Sandherr, M., Sieniawski, M., Vehreschild, J., Wolf, H. & Ullmann, A.J. (2009) Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies, Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica, 94, 113-122.
-
(2009)
Haematologica
, vol.94
, pp. 113-122
-
-
Cornely, O.A.1
Böhme, A.2
Buchheidt, D.3
Einsele, H.4
Heinz, W.J.5
Karthaus, M.6
Krause, S.W.7
Krüger, W.8
Maschmeyer, G.9
Penack, O.10
Ritter, J.11
Ruhnke, M.12
Sandherr, M.13
Sieniawski, M.14
Vehreschild, J.15
Wolf, H.16
Ullmann, A.J.17
-
15
-
-
33847266273
-
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
-
El-Cheikh, J., Faucher, C., Furst, S., Duran, S., Berger, P., Vey, N., Stoppa, A.-M., Bouabdallah, R., Gastaut, J.-A., Viens, P., Blaise, D. & Mohty, M. (2007) High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation, 39, 301-306.
-
(2007)
Bone Marrow Transplantation
, vol.39
, pp. 301-306
-
-
El-Cheikh, J.1
Faucher, C.2
Furst, S.3
Duran, S.4
Berger, P.5
Vey, N.6
Stoppa, A.-M.7
Bouabdallah, R.8
Gastaut, J.-A.9
Viens, P.10
Blaise, D.11
Mohty, M.12
-
16
-
-
0030970514
-
Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients
-
Erjavec, Z., Woolthuis, G.M., de Vries-Hospers, H.G., Sluiter, W.J., Daenen, S.M., de Pauw, B. & Halie, M.R. (1997) Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. European Journal of Clinical Microbiology and Infectious Diseases, 16, 364-368.
-
(1997)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.16
, pp. 364-368
-
-
Erjavec, Z.1
Woolthuis, G.M.2
de Vries-Hospers, H.G.3
Sluiter, W.J.4
Daenen, S.M.5
de Pauw, B.6
Halie, M.R.7
-
17
-
-
68249158188
-
Trends in invasive fungal infections, with emphasis on invasive aspergillosis
-
Erjavec, Z., Kluin-Nelemans, H. & Verweij, P.E. (2009) Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clinical Microbiology and Infection, 15, 625-633.
-
(2009)
Clinical Microbiology and Infection
, vol.15
, pp. 625-633
-
-
Erjavec, Z.1
Kluin-Nelemans, H.2
Verweij, P.E.3
-
18
-
-
0013805076
-
The nature and control of infections in patients with acute leukemia
-
Frei, III, E., Levin, R.H., Bodey, G.P., Morse, E.E. & Freireich, E.J. (1965) The nature and control of infections in patients with acute leukemia. Cancer Research, 25, 1511-1515.
-
(1965)
Cancer Research
, vol.25
, pp. 1511-1515
-
-
Frei III, E.1
Levin, R.H.2
Bodey, G.P.3
Morse, E.E.4
Freireich, E.J.5
-
19
-
-
53349157204
-
Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation
-
Garcia-Vidal, C., Upton, A., Kirby, K.A. & Marr, K.A. (2008) Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clinical Infectious Diseases, 47, 1041-1050.
-
(2008)
Clinical Infectious Diseases
, vol.47
, pp. 1041-1050
-
-
Garcia-Vidal, C.1
Upton, A.2
Kirby, K.A.3
Marr, K.A.4
-
20
-
-
77950629027
-
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD
-
Gergis, U., Markey, K., Greene, J., Kharfan-Dabaja, M., Field, T., Wetzstein, G., Schell, M.J., Huang, Y., Anasetti, C. & Perkins, J. (2009) Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD. Bone Marrow Transplantation, 45, 662-667.
-
(2009)
Bone Marrow Transplantation
, vol.45
, pp. 662-667
-
-
Gergis, U.1
Markey, K.2
Greene, J.3
Kharfan-Dabaja, M.4
Field, T.5
Wetzstein, G.6
Schell, M.J.7
Huang, Y.8
Anasetti, C.9
Perkins, J.10
-
21
-
-
59549093782
-
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT
-
Gil, L., Kozlowska-Skrzypczak, M., Mol, A., Poplawski, D., Styczynski, J. & Komarnicki, M. (2009) Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone Marrow Transplantation, 43, 121-126.
-
(2009)
Bone Marrow Transplantation
, vol.43
, pp. 121-126
-
-
Gil, L.1
Kozlowska-Skrzypczak, M.2
Mol, A.3
Poplawski, D.4
Styczynski, J.5
Komarnicki, M.6
-
22
-
-
0031958239
-
Severe vincristine toxicity in combination with itraconazole
-
Gillies, J., Hung, K.A., Fitzsimons, E. & Soutar, R. (1998) Severe vincristine toxicity in combination with itraconazole. Clinical Laboratory Haematology, 20, 123-124.
-
(1998)
Clinical Laboratory Haematology
, vol.20
, pp. 123-124
-
-
Gillies, J.1
Hung, K.A.2
Fitzsimons, E.3
Soutar, R.4
-
23
-
-
1542438612
-
Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients
-
Glasmacher, A., Prentice, A., Gorschluter, M., Engelhart, S., Hahn, C. & Djulbegovic, B. (2003) Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3, 597 patients. Journal of Clinical Oncology, 21, 4615-4626.
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 4615-4626
-
-
Glasmacher, A.1
Prentice, A.2
Gorschluter, M.3
Engelhart, S.4
Hahn, C.5
Djulbegovic, B.6
-
24
-
-
33847026522
-
Reply to Gotsche et al
-
Glasmacher, A., Prentice, A., Gorschluter, M., Engelhart, S., Hahn, C., Djulbegovic, B. & Schmidt-Wolf, I. (2005) Reply to Gotsche et al. Journal of Clinical Oncology, 23, 9429-9431.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 9429-9431
-
-
Glasmacher, A.1
Prentice, A.2
Gorschluter, M.3
Engelhart, S.4
Hahn, C.5
Djulbegovic, B.6
Schmidt-Wolf, I.7
-
25
-
-
0001348302
-
Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies
-
Gold, W., Stout, H.A., Pagano, J.F. & Donovick, R. (1956) Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. Antibiotics Annual 1955-1956, 3, 579-586.
-
(1956)
Antibiotics Annual 1955-1956
, vol.3
, pp. 579-586
-
-
Gold, W.1
Stout, H.A.2
Pagano, J.F.3
Donovick, R.4
-
26
-
-
0026597735
-
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
-
Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandrasekar, P.H., Fox, B., Kaizer, H., Shadduck, K., Shea, T.C., Stiff, P., Friedman, D.J., Powderly, W.G., Silber, J.L., Horowitz, H., Lichtin, A., Wolff, S.N., Mangan, K.F., Silver, S.M., Weisdorf, D., Ho, W.G., Gilbert, G. & Buell, D. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine, 326, 845-851.
-
(1992)
New England Journal of Medicine
, vol.326
, pp. 845-851
-
-
Goodman, J.L.1
Winston, D.J.2
Greenfield, R.A.3
Chandrasekar, P.H.4
Fox, B.5
Kaizer, H.6
Shadduck, K.7
Shea, T.C.8
Stiff, P.9
Friedman, D.J.10
Powderly, W.G.11
Silber, J.L.12
Horowitz, H.13
Lichtin, A.14
Wolff, S.N.15
Mangan, K.F.16
Silver, S.M.17
Weisdorf, D.18
Ho, W.G.19
Gilbert, G.20
Buell, D.21
more..
-
27
-
-
33644830188
-
Misleading statements in industry-sponsored meta-analysis of itraconazole
-
Gotzsche, P.C. & Johansen, H.K. (2005) Misleading statements in industry-sponsored meta-analysis of itraconazole. Journal of Clinical Oncology, 23, 9428-9429.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 9428-9429
-
-
Gotzsche, P.C.1
Johansen, H.K.2
-
28
-
-
77957828768
-
Accuracy of bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis: a bivariate meta-analysis and systematic review
-
Guo, Y.L., Chen, Y.Q., Wang, K., Qin, S.M., Wu, C. & Kong, J.L. (2010) Accuracy of bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis: a bivariate meta-analysis and systematic review. Chest, 138, 817-824.
-
(2010)
Chest
, vol.138
, pp. 817-824
-
-
Guo, Y.L.1
Chen, Y.Q.2
Wang, K.3
Qin, S.M.4
Wu, C.5
Kong, J.L.6
-
29
-
-
44649176508
-
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation
-
Hamadani, M., Hofmeister, C.C., Jansak, B., Phillips, G., Elder, P., Penza, S., Lin, T.S., Klisovic, R., Marcucci, G., Farag, S.S. & Devine, S.M. (2008) Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation. Biology of Blood and Marrow Transplantation, 14, 783-789.
-
(2008)
Biology of Blood and Marrow Transplantation
, vol.14
, pp. 783-789
-
-
Hamadani, M.1
Hofmeister, C.C.2
Jansak, B.3
Phillips, G.4
Elder, P.5
Penza, S.6
Lin, T.S.7
Klisovic, R.8
Marcucci, G.9
Farag, S.S.10
Devine, S.M.11
-
30
-
-
0020357755
-
The pharmacokinetics of ketoconazole in severely immunocompromised patients
-
Hann, I.M., Prentice, H.G., Keaney, M., Corringham, R., Blacklock, H.A., Fox, J., Gascoigne, E. & Van Cutsem, J. (1982a) The pharmacokinetics of ketoconazole in severely immunocompromised patients. Journal of Antimicrobial Chemotherapy, 10, 489-496.
-
(1982)
Journal of Antimicrobial Chemotherapy
, vol.10
, pp. 489-496
-
-
Hann, I.M.1
Prentice, H.G.2
Keaney, M.3
Corringham, R.4
Blacklock, H.A.5
Fox, J.6
Gascoigne, E.7
Van Cutsem, J.8
-
31
-
-
0020064358
-
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients
-
Hann, I.M., Prentice, H.G., Corringham, R., Blacklock, H.A., Keaney, M., Shannon, M., Noone, P., Gascoigne, E., Fox, J., Boesen, E., Szawatkowski, M. & Hoffbrand, A.V. (1982b) Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet, 1, 826-829.
-
(1982)
Lancet
, vol.1
, pp. 826-829
-
-
Hann, I.M.1
Prentice, H.G.2
Corringham, R.3
Blacklock, H.A.4
Keaney, M.5
Shannon, M.6
Noone, P.7
Gascoigne, E.8
Fox, J.9
Boesen, E.10
Szawatkowski, M.11
Hoffbrand, A.V.12
-
32
-
-
69849111376
-
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients
-
Harnicar, S., Adel, N. & Jurcic, J. (2009) Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients. Journal of Oncology Pharmacy Practice, 15, 175-182.
-
(2009)
Journal of Oncology Pharmacy Practice
, vol.15
, pp. 175-182
-
-
Harnicar, S.1
Adel, N.2
Jurcic, J.3
-
33
-
-
0033919037
-
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B
-
Harousseau, J.L., Dekker, A.W., Stamatoullas-Bastard, A., Fassas, A., Linkesch, W., Gouveia, J., De Bock, R., Rovira, M., Seifert, W.F., Joosen, H., Peeters, M. & De Beule, K. (2000) Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrobial Agents and Chemotherapy, 44, 1887-1893.
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, pp. 1887-1893
-
-
Harousseau, J.L.1
Dekker, A.W.2
Stamatoullas-Bastard, A.3
Fassas, A.4
Linkesch, W.5
Gouveia, J.6
De Bock, R.7
Rovira, M.8
Seifert, W.F.9
Joosen, H.10
Peeters, M.11
De Beule, K.12
-
35
-
-
40749161536
-
Beta-D-glucan detection test: a step towards preemptive therapy for fungal infections in leukaemic patients?
-
Herbrecht, R. & Berceanu, A. (2008) Beta-D-glucan detection test: a step towards preemptive therapy for fungal infections in leukaemic patients? Clinical Infectious Diseases, 46, 886-889.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 886-889
-
-
Herbrecht, R.1
Berceanu, A.2
-
36
-
-
0037043655
-
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
-
Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group
-
Herbrecht, R., Denning, D.W., Patterson, T.F., Bennett, J.E., Greene, R.E., Oestmann, J.W., Kern, W.V., Marr, K.A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R.H., Wingard, J.R., Stark, P., Durand, C., Caillot, D., Thiel, E., Chandrasekar, P.H., Hodges, M.R., Schlamm, H.T., Troke, P.F. & de Pauw, B.; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New England Journal of Medicine, 347, 408-415.
-
(2002)
New England Journal of Medicine
, vol.347
, pp. 408-415
-
-
Herbrecht, R.1
Denning, D.W.2
Patterson, T.F.3
Bennett, J.E.4
Greene, R.E.5
Oestmann, J.W.6
Kern, W.V.7
Marr, K.A.8
Ribaud, P.9
Lortholary, O.10
Sylvester, R.11
Rubin, R.H.12
Wingard, J.R.13
Stark, P.14
Durand, C.15
Caillot, D.16
Thiel, E.17
Chandrasekar, P.H.18
Hodges, M.R.19
Schlamm, H.T.20
Troke, P.F.21
de Pauw, B.22
more..
-
37
-
-
64249152006
-
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
-
West-Japan Hematology and Oncology Group
-
Hiramatsu, Y., Maeda, Y., Fujii, N., Saito, T., Nawa, Y., Hara, M., Yano, T., Asakura, S., Sunami, K., Tabayashi, T., Miyata, A., Matsuoka, K., Shinagawa, K., Ikedam, K., Matsuo, K. & Tanimoto, M.; West-Japan Hematology and Oncology Group. (2008) Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation. International Journal of Hematology, 88, 588-595.
-
(2008)
International Journal of Hematology
, vol.88
, pp. 588-595
-
-
Hiramatsu, Y.1
Maeda, Y.2
Fujii, N.3
Saito, T.4
Nawa, Y.5
Hara, M.6
Yano, T.7
Asakura, S.8
Sunami, K.9
Tabayashi, T.10
Miyata, A.11
Matsuoka, K.12
Shinagawa, K.13
Ikedam, K.14
Matsuo, K.15
Tanimoto, M.16
-
38
-
-
0032899153
-
Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology
-
Huijgens, P.C., Simoons-Smit, A.M., van Loenen, A.C., Prooy, E., van Tinteren, H., Ossenkoppele, G.J. & Jonkhoff, A.R. (1999) Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. Journal of Clinical Pathology, 52, 376-380.
-
(1999)
Journal of Clinical Pathology
, vol.52
, pp. 376-380
-
-
Huijgens, P.C.1
Simoons-Smit, A.M.2
van Loenen, A.C.3
Prooy, E.4
van Tinteren, H.5
Ossenkoppele, G.J.6
Jonkhoff, A.R.7
-
39
-
-
77953809369
-
Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma
-
Jang, S.H., Colangelo, P.M. & Gobburu, J.V. (2010) Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma. Clinical Pharmacology & Therapeutics, 88, 115-119.
-
(2010)
Clinical Pharmacology & Therapeutics
, vol.88
, pp. 115-119
-
-
Jang, S.H.1
Colangelo, P.M.2
Gobburu, J.V.3
-
40
-
-
0034565160
-
Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia
-
Johansen, H.K. & Gotzsche, P.C. (2000) Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia. Cochrane Database Systematic Reviews, 3, CD000969.
-
(2000)
Cochrane Database Systematic Reviews
, vol.3
-
-
Johansen, H.K.1
Gotzsche, P.C.2
-
41
-
-
0036042977
-
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
-
Johansen, H.K. & Gotzsche, P.C. (2002) Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. Cochrane Database Systematic Reviews, 2, CD000239.
-
(2002)
Cochrane Database Systematic Reviews
, vol.2
-
-
Johansen, H.K.1
Gotzsche, P.C.2
-
42
-
-
0034306850
-
Prophylactic action of oral fluconazole against fungal Infection in neutropenic patients A meta-analysis of 16 randomized, controlled trials
-
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., Kami, M., Akiyami, H., Hirai, H. & Togawa, A. (2000) Prophylactic action of oral fluconazole against fungal Infection in neutropenic patients A meta-analysis of 16 randomized, controlled trials. Cancer, 89, 1611-1625.
-
(2000)
Cancer
, vol.89
, pp. 1611-1625
-
-
Kanda, Y.1
Yamamoto, R.2
Chizuka, A.3
Hamaki, T.4
Suguro, M.5
Arai, C.6
Matsuyama, T.7
Takezako, N.8
Miwa, A.9
Kern, W.10
Kami, M.11
Akiyami, H.12
Hirai, H.13
Togawa, A.14
-
43
-
-
0032913885
-
Liposomal amphotericin B (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomized, double-blind, placebo-controlled study
-
Kelsey, S.M., Goldman, J.M., McCann, S., Newland, A.C., Scarffe, J.H., Oppenheim, B.A. & Mufti, G.J. (1999) Liposomal amphotericin B (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomized, double-blind, placebo-controlled study. Bone Marrow Transplantation, 23, 163-168.
-
(1999)
Bone Marrow Transplantation
, vol.23
, pp. 163-168
-
-
Kelsey, S.M.1
Goldman, J.M.2
McCann, S.3
Newland, A.C.4
Scarffe, J.H.5
Oppenheim, B.A.6
Mufti, G.J.7
-
44
-
-
0032527958
-
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study
-
Kern, W., Behre, G., Rudolf, T., Kerkhoff, A., Grote-Metke, A., Eimermacher, H., Kubica, U., Wörmann, B., Büchner, T. & Hiddemann, W. (1998) Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. Cancer, 83, 291-301.
-
(1998)
Cancer
, vol.83
, pp. 291-301
-
-
Kern, W.1
Behre, G.2
Rudolf, T.3
Kerkhoff, A.4
Grote-Metke, A.5
Eimermacher, H.6
Kubica, U.7
Wörmann, B.8
Büchner, T.9
Hiddemann, W.10
-
45
-
-
0035867087
-
Guide to the development of practice guidelines
-
Kish, M.A. (2001) Guide to the development of practice guidelines. Clinical Infectious Diseases, 32, 851-854.
-
(2001)
Clinical Infectious Diseases
, vol.32
, pp. 851-854
-
-
Kish, M.A.1
-
46
-
-
79951671840
-
Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success
-
Kontoyiannis, D.P. (2011) Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplantation, 46, 165-173.
-
(2011)
Bone Marrow Transplantation
, vol.46
, pp. 165-173
-
-
Kontoyiannis, D.P.1
-
47
-
-
20144389423
-
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases
-
Kontoyiannis, D.P., Lionakis, M.S., Lewis, R.E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T.J. & Raad, I. (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. Journal of Infectious Diseases, 191, 1350-1360.
-
(2005)
Journal of Infectious Diseases
, vol.191
, pp. 1350-1360
-
-
Kontoyiannis, D.P.1
Lionakis, M.S.2
Lewis, R.E.3
Chamilos, G.4
Healy, M.5
Perego, C.6
Safdar, A.7
Kantarjian, H.8
Champlin, R.9
Walsh, T.J.10
Raad, I.11
-
48
-
-
77950280868
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
-
Kontoyiannis, D.P., Marr, K.A., Park, B.J., Alexander, B.D., Anaissie, E.J., Walsh, T.J., Ito, J., Andes, D.R., Baddley, J.W., Brown, J.M., Brumble, L.M., Freifeld, A.G., Hadley, S., Herwaldt, L.A., Kauffman, C.A., Knapp, K., Lyon, G.M., Morrison, V.A., Papanicolaou, G., Patterson, T.F., Perl, T.M., Schuster, M.G., Walker, R., Wannemuehler, K.A., Wingard, J.R., Chiller, T.M. & Pappas, P.G. (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clinical Infectious Diseases, 50, 1091-1100.
-
(2010)
Clinical Infectious Diseases
, vol.50
, pp. 1091-1100
-
-
Kontoyiannis, D.P.1
Marr, K.A.2
Park, B.J.3
Alexander, B.D.4
Anaissie, E.J.5
Walsh, T.J.6
Ito, J.7
Andes, D.R.8
Baddley, J.W.9
Brown, J.M.10
Brumble, L.M.11
Freifeld, A.G.12
Hadley, S.13
Herwaldt, L.A.14
Kauffman, C.A.15
Knapp, K.16
Lyon, G.M.17
Morrison, V.A.18
Papanicolaou, G.19
Patterson, T.F.20
Perl, T.M.21
Schuster, M.G.22
Walker, R.23
Wannemuehler, K.A.24
Wingard, J.R.25
Chiller, T.M.26
Pappas, P.G.27
more..
-
49
-
-
63849233258
-
The changing face of epidemiology of invasive fungal disease in Europe
-
Lass-Florl, C. (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses, 52, 197-205.
-
(2009)
Mycoses
, vol.52
, pp. 197-205
-
-
Lass-Florl, C.1
-
50
-
-
84965190913
-
Galactomannan detection for invasive aspergillosis in immunocompromized patients
-
Leeflang, M.M., Debets-Ossenkopp, Y.J., Visser, C.E., Scholten, R.J., Hooft, L., Bijlmer, H.A., Reitsma, J.B., Bossuyt, P.M. & Vandenbroucke-Grauls, C.M. (2008) Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane database Systematic Reviews October, 8, CD007394.
-
(2008)
Cochrane database Systematic Reviews October
, vol.8
-
-
Leeflang, M.M.1
Debets-Ossenkopp, Y.J.2
Visser, C.E.3
Scholten, R.J.4
Hooft, L.5
Bijlmer, H.A.6
Reitsma, J.B.7
Bossuyt, P.M.8
Vandenbroucke-Grauls, C.M.9
-
51
-
-
75749148763
-
Fungal infections in leukemia patients: how do we prevent and treat them?
-
Leventakos, K., Lewis, R.E. & Kontoyiannis, D.P. (2010) Fungal infections in leukemia patients: how do we prevent and treat them? Clinical Infectious Diseases, 50, 405-415.
-
(2010)
Clinical Infectious Diseases
, vol.50
, pp. 405-415
-
-
Leventakos, K.1
Lewis, R.E.2
Kontoyiannis, D.P.3
-
52
-
-
0036532505
-
Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy
-
MacMillan, M.L., Goodman, J.L., DeFor, T.E. & Weisdorf, D.J. (2002) Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. American Journal of Medicine, 112, 369-379.
-
(2002)
American Journal of Medicine
, vol.112
, pp. 369-379
-
-
MacMillan, M.L.1
Goodman, J.L.2
DeFor, T.E.3
Weisdorf, D.J.4
-
53
-
-
27444447144
-
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study
-
Maertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M. & Van Eldere, J. (2005) Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clinical Infectious Diseases, 41, 1242-1250.
-
(2005)
Clinical Infectious Diseases
, vol.41
, pp. 1242-1250
-
-
Maertens, J.1
Theunissen, K.2
Verhoef, G.3
Verschakelen, J.4
Lagrou, K.5
Verbeken, E.6
Wilmer, A.7
Verhaegen, J.8
Boogaerts, M.9
Van Eldere, J.10
-
54
-
-
33750524231
-
Preemptive antifungal therapy: still a way to go
-
Maertens, J., Deeren, D., Dierickx, D. & Theunissen, K. (2006) Preemptive antifungal therapy: still a way to go. Current Opinion in Infectious Diseases, 19, 551-556.
-
(2006)
Current Opinion in Infectious Diseases
, vol.19
, pp. 551-556
-
-
Maertens, J.1
Deeren, D.2
Dierickx, D.3
Theunissen, K.4
-
55
-
-
79955913668
-
European guidelines for antifungal management in leukemia and hematopoietc stem cell transplant recipients: summary of the ECIL 3-2009 update
-
Maertens, J., Marchetti, O., Herbrecht, R., Cornely, O.A., Fluckiger, U., Frere, P., Gachot, B., Heinz, W.J., Lass-Florl, C., Ribaud, P., Thiebaut, A. & Cordonnier, C. (2010) European guidelines for antifungal management in leukemia and hematopoietc stem cell transplant recipients: summary of the ECIL 3-2009 update. Bone Marrow Transplantation, doi:
-
(2010)
Bone Marrow Transplantation
-
-
Maertens, J.1
Marchetti, O.2
Herbrecht, R.3
Cornely, O.A.4
Fluckiger, U.5
Frere, P.6
Gachot, B.7
Heinz, W.J.8
Lass-Florl, C.9
Ribaud, P.10
Thiebaut, A.11
Cordonnier, C.12
-
56
-
-
79957552733
-
-
Improvit Study Group. Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant (HCT) recipients. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. © American Society for Microbiology, Washington, D.C. Abstract 1249A.
-
Marks, D.I., Kibbler, C., Pagliuca, A., Ribaud, P., Solano, C., Huessel, C.P., Cook, G., Glasmacher, A., Schlamm, H. & Kantecki, M.; Improvit Study Group. (2009) Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant (HCT) recipients. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. © American Society for Microbiology, Washington, D.C. Abstract 1249A.
-
(2009)
-
-
Marks, D.I.1
Kibbler, C.2
Pagliuca, A.3
Ribaud, P.4
Solano, C.5
Huessel, C.P.6
Cook, G.7
Glasmacher, A.8
Schlamm, H.9
Kantecki, M.10
-
57
-
-
0034665657
-
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
-
Marr, K.A., Seidel, K., Slavin, M.A., Bowden, R.A., Schoch, H.G., Flowers, M.E.D., Corey, L. & Boeckh, M. (2000) Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood, 96, 2055-2061.
-
(2000)
Blood
, vol.96
, pp. 2055-2061
-
-
Marr, K.A.1
Seidel, K.2
Slavin, M.A.3
Bowden, R.A.4
Schoch, H.G.5
Flowers, M.E.D.6
Corey, L.7
Boeckh, M.8
-
58
-
-
0035173979
-
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans
-
Marr, K.A., Lyons, C.N., Ha, K., Rustad, T.R. & White, T.C. (2001) Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrobial Agents and Chemotherapy, 45, 52-59.
-
(2001)
Antimicrobial Agents and Chemotherapy
, vol.45
, pp. 52-59
-
-
Marr, K.A.1
Lyons, C.N.2
Ha, K.3
Rustad, T.R.4
White, T.C.5
-
59
-
-
0037114705
-
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
-
Marr, K.A., Carter, R.A., Boeckh, M., Martin, P. & Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358-4366.
-
(2002)
Blood
, vol.100
, pp. 4358-4366
-
-
Marr, K.A.1
Carter, R.A.2
Boeckh, M.3
Martin, P.4
Corey, L.5
-
60
-
-
0842328814
-
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
-
Marr, K.A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S.A., Nichols, W.G., Musher, B. & Corey, L. (2004a) Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood, 103, 1527-1533.
-
(2004)
Blood
, vol.103
, pp. 1527-1533
-
-
Marr, K.A.1
Crippa, F.2
Leisenring, W.3
Hoyle, M.4
Boeckh, M.5
Balajee, S.A.6
Nichols, W.G.7
Musher, B.8
Corey, L.9
-
61
-
-
0842307309
-
Cyclophosphamide metabolism is affected by azole antifungals
-
Marr, K.A., Leisenring, W., Crippa, F., Slattery, J.T., Corey, L., Boeckh, M. & McDonald, G.B. (2004b) Cyclophosphamide metabolism is affected by azole antifungals. Blood, 103, 1557-1559.
-
(2004)
Blood
, vol.103
, pp. 1557-1559
-
-
Marr, K.A.1
Leisenring, W.2
Crippa, F.3
Slattery, J.T.4
Corey, L.5
Boeckh, M.6
McDonald, G.B.7
-
62
-
-
20444371963
-
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay
-
Marr, K.A., Laverdiere, M., Gugel, A. & Leisenring, W. (2005) Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clinical Infectious Diseases, 40, 1762-1769.
-
(2005)
Clinical Infectious Diseases
, vol.40
, pp. 1762-1769
-
-
Marr, K.A.1
Laverdiere, M.2
Gugel, A.3
Leisenring, W.4
-
63
-
-
70350787236
-
Fungal infection prevention after hematopoietic cell transplantation
-
Marr, K.A., Bow, E., Chiller, T., Maschmeyer, G., Ribaud, P., Segal, B., Steinbach, W., Wingard, J.R. & Nucci, M. (2009) Fungal infection prevention after hematopoietic cell transplantation. Bone Marrow Transplantation, 44, 483-487.
-
(2009)
Bone Marrow Transplantation
, vol.44
, pp. 483-487
-
-
Marr, K.A.1
Bow, E.2
Chiller, T.3
Maschmeyer, G.4
Ribaud, P.5
Segal, B.6
Steinbach, W.7
Wingard, J.R.8
Nucci, M.9
-
64
-
-
0141928771
-
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study
-
Marty, F.M., Lee, S.J., Fahey, M.M., Alyea, E.P., Soiffer, R.J., Antin, J.H. & Baden, L.R. (2003) Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood, 102, 2768-2776.
-
(2003)
Blood
, vol.102
, pp. 2768-2776
-
-
Marty, F.M.1
Lee, S.J.2
Fahey, M.M.3
Alyea, E.P.4
Soiffer, R.J.5
Antin, J.H.6
Baden, L.R.7
-
65
-
-
1342331879
-
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
-
Marty, F.M., Cosimi, L.A. & Baden, L.R. (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. New England Journal of Medicine, 350, 950-952.
-
(2004)
New England Journal of Medicine
, vol.350
, pp. 950-952
-
-
Marty, F.M.1
Cosimi, L.A.2
Baden, L.R.3
-
66
-
-
9144238092
-
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy
-
Mattiuzzi, G.N., Kantarjian, H., Faderl, S., Lim, J., Kontoyiannis, D., Thomas, D., Wierda, W., Raad, I., Garcia-Manero, G., Zhou, X., Ferrajoli, A., Bekeli, N. & Estey, E. (2004) Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer, 100, 581-589.
-
(2004)
Cancer
, vol.100
, pp. 581-589
-
-
Mattiuzzi, G.N.1
Kantarjian, H.2
Faderl, S.3
Lim, J.4
Kontoyiannis, D.5
Thomas, D.6
Wierda, W.7
Raad, I.8
Garcia-Manero, G.9
Zhou, X.10
Ferrajoli, A.11
Bekeli, N.12
Estey, E.13
-
67
-
-
29944444166
-
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies
-
Mattiuzzi, G.N., Alvarado, G., Giles, F.J., Ostrosky-Zeichner, L., Cortes, J., O'Brien, S., Verstovsek, S., Faderl, S., Zhou, X., Raad, I.I., Bekele, B.N., Leitz, G.J., Lopez-Roman, I. & Estey, E.H. (2006) Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies. Antimicrobial Agents and Chemotherapy, 50, 143-147.
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, pp. 143-147
-
-
Mattiuzzi, G.N.1
Alvarado, G.2
Giles, F.J.3
Ostrosky-Zeichner, L.4
Cortes, J.5
O'Brien, S.6
Verstovsek, S.7
Faderl, S.8
Zhou, X.9
Raad, I.I.10
Bekele, B.N.11
Leitz, G.J.12
Lopez-Roman, I.13
Estey, E.H.14
-
68
-
-
78651490152
-
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
-
Mattiuzzi, G.N., Cortes, J., Alvarado, G., Verstovsek, S., Koller, C., Pierce, S., Blamble, D., Faderl, S., Xiao, L., Hernandez, M. & Kantarjian, H. (2011) Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Support Care Cancer, 19, 19-26.
-
(2011)
Support Care Cancer
, vol.19
, pp. 19-26
-
-
Mattiuzzi, G.N.1
Cortes, J.2
Alvarado, G.3
Verstovsek, S.4
Koller, C.5
Pierce, S.6
Blamble, D.7
Faderl, S.8
Xiao, L.9
Hernandez, M.10
Kantarjian, H.11
-
69
-
-
58549118484
-
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
-
Mengoli, C., Cruciani, M., Barnes, R.A., Loeffler, J. & Donnelly, J.P. (2009) Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infectious Diseases, 9, 89-96.
-
(2009)
Lancet Infectious Diseases
, vol.9
, pp. 89-96
-
-
Mengoli, C.1
Cruciani, M.2
Barnes, R.A.3
Loeffler, J.4
Donnelly, J.P.5
-
70
-
-
0028243197
-
Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B
-
GIMEMA Infection Program.
-
Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., D'Antonio, D., Ricci, P., Carotenuto, M., Liso, V., Nosari, A.M., Barbui, T., Fasola, G. & Mandelli, F.; GIMEMA Infection Program. (1994) Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Annals of Internal Medicine, 120, 913-918.
-
(1994)
Annals of Internal Medicine
, vol.120
, pp. 913-918
-
-
Menichetti, F.1
Del Favero, A.2
Martino, P.3
Bucaneve, G.4
Micozzi, A.5
D'Antonio, D.6
Ricci, P.7
Carotenuto, M.8
Liso, V.9
Nosari, A.M.10
Barbui, T.11
Fasola, G.12
Mandelli, F.13
-
71
-
-
0033047475
-
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with haematological malignancies: a randomized, placebo-controlled, double-blind, multicentre trial. GIMEMA Infection Program
-
Menichetti, F., Del Favero, A., Martino, P., Bucaneve., G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagańo, L., Leoni, P., Specchia, G., Caiozzo, A., Raimondi, R. & Mandelli, F. (1999) Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with haematological malignancies: a randomized, placebo-controlled, double-blind, multicentre trial. GIMEMA Infection Program. Clinical Infectious Diseases, 28, 250-255.
-
(1999)
Clinical Infectious Diseases
, vol.28
, pp. 250-255
-
-
Menichetti, F.1
Del Favero, A.2
Martino, P.3
Bucaneve, G.4
Micozzi, A.5
Girmenia, C.6
Barbabietola, G.7
Pagańo, L.8
Leoni, P.9
Specchia, G.10
Caiozzo, A.11
Raimondi, R.12
Mandelli, F.13
-
72
-
-
0032991690
-
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. UK Multicentre Antifungal Prophylaxis Study Group
-
Morgenstern, G.R., Prentice, A.G., Prentice, H.G., Ropner, J.E., Schey, S.A. & Warnock, D.W. (1999) A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. UK Multicentre Antifungal Prophylaxis Study Group. British Journal of Haematology, 105, 901-911.
-
(1999)
British Journal of Haematology
, vol.105
, pp. 901-911
-
-
Morgenstern, G.R.1
Prentice, A.G.2
Prentice, H.G.3
Ropner, J.E.4
Schey, S.A.5
Warnock, D.W.6
-
73
-
-
58749083534
-
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective Antifungal Therapy (PATH) Path Alliance Registry
-
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K. & Marr, K. (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective Antifungal Therapy (PATH) Path Alliance Registry. Clinical Infectious Diseases, 48, 265-273.
-
(2009)
Clinical Infectious Diseases
, vol.48
, pp. 265-273
-
-
Neofytos, D.1
Horn, D.2
Anaissie, E.3
Steinbach, W.4
Olyaei, A.5
Fishman, J.6
Pfaller, M.7
Chang, C.8
Webster, K.9
Marr, K.10
-
74
-
-
0035893122
-
Revisiting the source of candidemia: skin or gut?
-
Nucci, M. & Anaissie, E. (2001) Revisiting the source of candidemia: skin or gut? Clinical Infectious Diseases, 33, 1959-1967.
-
(2001)
Clinical Infectious Diseases
, vol.33
, pp. 1959-1967
-
-
Nucci, M.1
Anaissie, E.2
-
75
-
-
0034099841
-
A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients
-
Nucci, M., Biasoli, I., Akiti, T., Silveira, F., Solza, C., Barreiros, G., Spector, N., Derossi, A. & Pulcheri, W. (2000) A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Clinical Infectious Diseases, 30, 300-305.
-
(2000)
Clinical Infectious Diseases
, vol.30
, pp. 300-305
-
-
Nucci, M.1
Biasoli, I.2
Akiti, T.3
Silveira, F.4
Solza, C.5
Barreiros, G.6
Spector, N.7
Derossi, A.8
Pulcheri, W.9
-
76
-
-
33747055130
-
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study
-
Pagano, L., Caira, M., Candoni, A., Offidani, M., Fianchi, L., Martino, B., Pastore, D., Picardi, M., Bonini, A., Chierichini, A., Fanci, R., Caramatti, C., Invernicci, R., Mattei, D., Mitra, M.E., Melillo, L., Aversa, F., Van Lint, M.T., Falcucci, P., Valentini, C.G., Girmenia, C. & Nosari, A. (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica, 91, 1068-1075.
-
(2006)
Haematologica
, vol.91
, pp. 1068-1075
-
-
Pagano, L.1
Caira, M.2
Candoni, A.3
Offidani, M.4
Fianchi, L.5
Martino, B.6
Pastore, D.7
Picardi, M.8
Bonini, A.9
Chierichini, A.10
Fanci, R.11
Caramatti, C.12
Invernicci, R.13
Mattei, D.14
Mitra, M.E.15
Melillo, L.16
Aversa, F.17
Van Lint, M.T.18
Falcucci, P.19
Valentini, C.G.20
Girmenia, C.21
Nosari, A.22
more..
-
77
-
-
77950682818
-
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study
-
Pagano, L., Caira, M., Candoni, A., Offidani, M., Martino, B., Specchia, G., Pastore, D., Stanzani, M., Cattaneo, C., Fanci, R., Caramatti, C., Rossini, F., Luppi, M., Potenza, L., Ferrara, F., Mitra, M.E., Fadda, R.M., Invernizzi, R., Aloisi, T., Picardi, M., Bonini, A., Vacca, A., Chierichini, A., Melillo, L., de Waure, C., Fianchi, L., Riva, M., Leone, G., Aversa, F. & Nosari, A. (2010) Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. Haematologica, 95, 644-650.
-
(2010)
Haematologica
, vol.95
, pp. 644-650
-
-
Pagano, L.1
Caira, M.2
Candoni, A.3
Offidani, M.4
Martino, B.5
Specchia, G.6
Pastore, D.7
Stanzani, M.8
Cattaneo, C.9
Fanci, R.10
Caramatti, C.11
Rossini, F.12
Luppi, M.13
Potenza, L.14
Ferrara, F.15
Mitra, M.E.16
Fadda, R.M.17
Invernizzi, R.18
Aloisi, T.19
Picardi, M.20
Bonini, A.21
Vacca, A.22
Chierichini, A.23
Melillo, L.24
de Waure, C.25
Fianchi, L.26
Riva, M.27
Leone, G.28
Aversa, F.29
Nosari, A.30
more..
-
78
-
-
60549098868
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
-
Pappas, P.G., Kauffman, C.A., Andes, D., Benjamin, Jr, D.K., Calandra, T.F., Edwards, Jr, J.E., Filler, S.G., Fisher, J.F., Kullberg, B.-J., Reboli, A.C., Rex, J.H., Walsh, T.J. & Sobel, J.D. (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 48, 503-535.
-
(2009)
Clinical Infectious Diseases
, vol.48
, pp. 503-535
-
-
Pappas, P.G.1
Kauffman, C.A.2
Andes, D.3
Benjamin Jr, D.K.4
Calandra, T.F.5
Edwards Jr, J.E.6
Filler, S.G.7
Fisher, J.F.8
Kullberg, B.-J.9
Reboli, A.C.10
Rex, J.H.11
Walsh, T.J.12
Sobel, J.D.13
-
79
-
-
39449117139
-
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
-
Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J. & Marchetti, O. (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clinical Infectious Diseases, 46, 201-211.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 201-211
-
-
Pascual, A.1
Calandra, T.2
Bolay, S.3
Buclin, T.4
Bille, J.5
Marchetti, O.6
-
80
-
-
33846439749
-
Prophylaxis and aspergillosis - has the principle been proven?
-
de Pauw, B.E. & Donnelly, J.P. (2007) Prophylaxis and aspergillosis - has the principle been proven? New England Journal of Medicine, 356, 409-411.
-
(2007)
New England Journal of Medicine
, vol.356
, pp. 409-411
-
-
de Pauw, B.E.1
Donnelly, J.P.2
-
81
-
-
63649130507
-
Timely intervention for invasive fungal disease: should the road lead to the laboratory instead of the pharmacy?
-
de Pauw, B.E. & Donnelly, J.P. (2009) Timely intervention for invasive fungal disease: should the road lead to the laboratory instead of the pharmacy? Clinical Infectious Diseases, 48, 1052-1054.
-
(2009)
Clinical Infectious Diseases
, vol.48
, pp. 1052-1054
-
-
de Pauw, B.E.1
Donnelly, J.P.2
-
82
-
-
46249126149
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
-
de Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., Pappas, P.G., Maertens, J., Lortholary, O., Kauffman, C.A., Denning, D.W., Patterson, T.F., Maschmeyer, G., Bille, J., Dismukes, W.E., Herbrecht, R., Hope, W.W., Kibbler, C.C., Kullberg, B.J., Marr, K.A., Munoz, P., Odds, F.C., Perfect, J.R., Restrepo, A., Ruhnke, M., Segal, B.H., Sobel, J.D., Sorrell, T.C., Viscoli, C., Wingard, J.R., Zaoutis, T. & Bennett, J.E. (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases, 46, 1813-1821.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 1813-1821
-
-
de Pauw, B.1
Walsh, T.J.2
Donnelly, J.P.3
Stevens, D.A.4
Edwards, J.E.5
Calandra, T.6
Pappas, P.G.7
Maertens, J.8
Lortholary, O.9
Kauffman, C.A.10
Denning, D.W.11
Patterson, T.F.12
Maschmeyer, G.13
Bille, J.14
Dismukes, W.E.15
Herbrecht, R.16
Hope, W.W.17
Kibbler, C.C.18
Kullberg, B.J.19
Marr, K.A.20
Munoz, P.21
Odds, F.C.22
Perfect, J.R.23
Restrepo, A.24
Ruhnke, M.25
Segal, B.H.26
Sobel, J.D.27
Sorrell, T.C.28
Viscoli, C.29
Wingard, J.R.30
Zaoutis, T.31
Bennett, J.E.32
more..
-
83
-
-
33747892111
-
Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
-
Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt-Hieber, M., Thiel, E. & Blau, I.W. (2006) Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. Annals of Oncology, 17, 1306-1312.
-
(2006)
Annals of Oncology
, vol.17
, pp. 1306-1312
-
-
Penack, O.1
Schwartz, S.2
Martus, P.3
Reinwald, M.4
Schmidt-Hieber, M.5
Thiel, E.6
Blau, I.W.7
-
84
-
-
42549119120
-
Aerosolized antifungal prophylaxis: the winds of change?
-
Perfect, J.R. (2008) Aerosolized antifungal prophylaxis: the winds of change? Clinical Infectious Diseases, 46, 1409-1411.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 1409-1411
-
-
Perfect, J.R.1
-
85
-
-
0026539280
-
Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients
-
Perfect, J.R., Klotman, M.E., Gilbert, C.C., Crawford, D.D., Rosner, G.L., Wright, K.A. & Peters, W.P. (1992) Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. Journal of Infectious Diseases, 165, 891-897.
-
(1992)
Journal of Infectious Diseases
, vol.165
, pp. 891-897
-
-
Perfect, J.R.1
Klotman, M.E.2
Gilbert, C.C.3
Crawford, D.D.4
Rosner, G.L.5
Wright, K.A.6
Peters, W.P.7
-
86
-
-
33646464211
-
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis
-
Pfeiffer, C.D., Fine, J.P. & Safdar, N. (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clinical Infectious Diseases, 42, 1417-1427.
-
(2006)
Clinical Infectious Diseases
, vol.42
, pp. 1417-1427
-
-
Pfeiffer, C.D.1
Fine, J.P.2
Safdar, N.3
-
87
-
-
0027248742
-
Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group
-
Philpott-Howard, J.N., Wade, J.J., Mufti, G.J., Brammer, K.W. & Ehninger, G. (1993) Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. Journal of Antimicrobial Chemotherapy, 31, 973-984.
-
(1993)
Journal of Antimicrobial Chemotherapy
, vol.31
, pp. 973-984
-
-
Philpott-Howard, J.N.1
Wade, J.J.2
Mufti, G.J.3
Brammer, K.W.4
Ehninger, G.5
-
88
-
-
42549085783
-
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial
-
Rijnders, B.J., Cornelissen, J.J., Slobbe, L., Becker, M.J., Doorduijn, J.K., Hop, W.C., Ruijgrok, E.J., Löwenberg, B., Vulto, A., Lugtenburg, P.J. & de Marie, S. (2008) Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clinical Infectious Diseases, 46, 1401-1408.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 1401-1408
-
-
Rijnders, B.J.1
Cornelissen, J.J.2
Slobbe, L.3
Becker, M.J.4
Doorduijn, J.K.5
Hop, W.C.6
Ruijgrok, E.J.7
Löwenberg, B.8
Vulto, A.9
Lugtenburg, P.J.10
de Marie, S.11
-
89
-
-
0028039104
-
The prophylactic use of low-dose amphotericin B in bone marrow transplant patients
-
Riley, D.K., Pavia, A.T., Beatty, P.G., Petersen, F.B., Spruance, J.L. & Stokes, R. (1994) The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. American Journal of Medicine, 97, 509-514.
-
(1994)
American Journal of Medicine
, vol.97
, pp. 509-514
-
-
Riley, D.K.1
Pavia, A.T.2
Beatty, P.G.3
Petersen, F.B.4
Spruance, J.L.5
Stokes, R.6
-
90
-
-
36849012946
-
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis
-
Robenshtok, E., Gafter-Gvili, A., Goldberg, E., Weinberger, M., Yeshurun, M., Leibovici, L. & Paul, M. (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. Journal of Clinical Oncology, 25, 5471-5489.
-
(2007)
Journal of Clinical Oncology
, vol.25
, pp. 5471-5489
-
-
Robenshtok, E.1
Gafter-Gvili, A.2
Goldberg, E.3
Weinberger, M.4
Yeshurun, M.5
Leibovici, L.6
Paul, M.7
-
91
-
-
58849147928
-
Newer antifungal agents for invasive fungal infections in patients with haematological malignancy
-
Rogers, T.R. & Frost, S. (2009) Newer antifungal agents for invasive fungal infections in patients with haematological malignancy. British Journal of Haematology, 144, 629-641.
-
(2009)
British Journal of Haematology
, vol.144
, pp. 629-641
-
-
Rogers, T.R.1
Frost, S.2
-
92
-
-
0033014809
-
Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group
-
Rotstein, C., Bow, E.J., Laverdiere, M., Ioannou, S., Carr, D. & Moghaddam, N. (1999) Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clinical Infectious Diseases, 28, 331-340.
-
(1999)
Clinical Infectious Diseases
, vol.28
, pp. 331-340
-
-
Rotstein, C.1
Bow, E.J.2
Laverdiere, M.3
Ioannou, S.4
Carr, D.5
Moghaddam, N.6
-
93
-
-
79957536793
-
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation
-
Sanchez-Ortega, I., Patino, B., Arnan, M., Peralta, T., Parody, R., Gudiol, C., Encuentra, M., Fernandez de Sevilla, A. & Duarte, R.F. (2010) Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation. Bone Marrow Transplantation, doi: .
-
(2010)
Bone Marrow Transplantation
-
-
Sanchez-Ortega, I.1
Patino, B.2
Arnan, M.3
Peralta, T.4
Parody, R.5
Gudiol, C.6
Encuentra, M.7
Fernandez de Sevilla, A.8
Duarte, R.F.9
-
94
-
-
36749026613
-
Posaconazole: an extended-spectrum triazole antifungal agent
-
Schiller, D.S. & Fung, H. (2007) Posaconazole: an extended-spectrum triazole antifungal agent. Clinical Therapeutics, 29, 1862-1886.
-
(2007)
Clinical Therapeutics
, vol.29
, pp. 1862-1886
-
-
Schiller, D.S.1
Fung, H.2
-
95
-
-
0033152309
-
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial
-
Schwartz, S., Behre, G., Heinemann, V., Wandt, H., Schilling, E., Arning, M., Trittin, A., Kern, W.V., Boenisch, O., Bosse, D., Lenz, K., Ludwig, W.D., Hiddemann, W., Siegert, W. & Beyer, J. (1999) Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood, 93, 3654-3661.
-
(1999)
Blood
, vol.93
, pp. 3654-3661
-
-
Schwartz, S.1
Behre, G.2
Heinemann, V.3
Wandt, H.4
Schilling, E.5
Arning, M.6
Trittin, A.7
Kern, W.V.8
Boenisch, O.9
Bosse, D.10
Lenz, K.11
Ludwig, W.D.12
Hiddemann, W.13
Siegert, W.14
Beyer, J.15
-
96
-
-
33846434112
-
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts
-
Segal, B.H., Almyroudis, N.G., Battiwalla, M., Herbrecht, R., Perfect, J.R. & Walsh, T.J. (2007) Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clinical Infectious Diseases, 44, 402-409.
-
(2007)
Clinical Infectious Diseases
, vol.44
, pp. 402-409
-
-
Segal, B.H.1
Almyroudis, N.G.2
Battiwalla, M.3
Herbrecht, R.4
Perfect, J.R.5
Walsh, T.J.6
-
97
-
-
40749151917
-
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia
-
Senn, L., Robinson, J.O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J., Calandra, T. & Marchetti, O. (2008) 1, 3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clinical Infectious Diseases, 46, 878-885.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 878-885
-
-
Senn, L.1
Robinson, J.O.2
Schmidt, S.3
Knaup, M.4
Asahi, N.5
Satomura, S.6
Matsuura, S.7
Duvoisin, B.8
Bille, J.9
Calandra, T.10
Marchetti, O.11
-
98
-
-
0022738443
-
Cyclosporine-ketoconazole: a potentially dangerous drug-drug interaction
-
Shepard, J.H., Canafax, D.M., Simmons, R.L. & Najarian, J.S. (1986) Cyclosporine-ketoconazole: a potentially dangerous drug-drug interaction. Clinical Pharmacology, 5, 468.
-
(1986)
Clinical Pharmacology
, vol.5
, pp. 468
-
-
Shepard, J.H.1
Canafax, D.M.2
Simmons, R.L.3
Najarian, J.S.4
-
99
-
-
0028997086
-
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study
-
Slavin, M.A., Osborne, B., Adams, R., Levenstein, M.J., Schoch, H.G., Feldman, A.R., Meyers, J.D. & Bowden, R.A. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. Journal of Infectious Diseases, 171, 1545-1552.
-
(1995)
Journal of Infectious Diseases
, vol.171
, pp. 1545-1552
-
-
Slavin, M.A.1
Osborne, B.2
Adams, R.3
Levenstein, M.J.4
Schoch, H.G.5
Feldman, A.R.6
Meyers, J.D.7
Bowden, R.A.8
-
100
-
-
46149096252
-
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy
-
Slavin, M.A., Heath, C.H., Thursky, K.A., Morrissey, C.O., Szer, J., Ling, L.M., Milliken, S.T. & Grigg, A.P. (2008) Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. Internal Medicine Journal, 38, 468-476.
-
(2008)
Internal Medicine Journal
, vol.38
, pp. 468-476
-
-
Slavin, M.A.1
Heath, C.H.2
Thursky, K.A.3
Morrissey, C.O.4
Szer, J.5
Ling, L.M.6
Milliken, S.T.7
Grigg, A.P.8
-
101
-
-
0012956488
-
Amphotericin B, a new antifungal agent for the prophylaxis of antibiotic-induced moniliasis
-
Stough, A.R., Groel, J.T. & Kroeger, W.H. (1959) Amphotericin B, a new antifungal agent for the prophylaxis of antibiotic-induced moniliasis. Antibiotic Medicines and Clinical Therapy, 6, 653-661.
-
(1959)
Antibiotic Medicines and Clinical Therapy
, vol.6
, pp. 653-661
-
-
Stough, A.R.1
Groel, J.T.2
Kroeger, W.H.3
-
102
-
-
4043077767
-
Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
-
Thursky, K.A., Byrnes, G., Grigg, A., Szer, J. & Slavin, M.A. (2004) Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation. Bone Marrow Transplantation, 34, 115-121.
-
(2004)
Bone Marrow Transplantation
, vol.34
, pp. 115-121
-
-
Thursky, K.A.1
Byrnes, G.2
Grigg, A.3
Szer, J.4
Slavin, M.A.5
-
103
-
-
33644790476
-
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab
-
Thursky, K.A., Worth, L.J., Seymour, J.F., Prince, H.M. & Slavin, M.A. (2006) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. British Journal of Haematology, 132, 3-12.
-
(2006)
British Journal of Haematology
, vol.132
, pp. 3-12
-
-
Thursky, K.A.1
Worth, L.J.2
Seymour, J.F.3
Prince, H.M.4
Slavin, M.A.5
-
104
-
-
0027715740
-
Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients
-
Tollemar, J., Ringden, O., Andersson, S., Sundberg, B., Ljungman, P. & Tydén, G. (1993) Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation, 12, 577-582.
-
(1993)
Bone Marrow Transplantation
, vol.12
, pp. 577-582
-
-
Tollemar, J.1
Ringden, O.2
Andersson, S.3
Sundberg, B.4
Ljungman, P.5
Tydén, G.6
-
105
-
-
67049107823
-
Inhaled voriconazole for the prevention of invasive pulmonary aspergillosis
-
Tolman, J.A., Wiederhold, N.P., McConville, J.T., Najvar, L.K., Bocanegra, R., Peters, J.I., Coalson, J.J., Graybill, J.R., Patterson, T.F. & Williams, III, R.O. (2009) Inhaled voriconazole for the prevention of invasive pulmonary aspergillosis. Antimicrobial Agents & Chemotherapy, 53, 2613-2615.
-
(2009)
Antimicrobial Agents & Chemotherapy
, vol.53
, pp. 2613-2615
-
-
Tolman, J.A.1
Wiederhold, N.P.2
McConville, J.T.3
Najvar, L.K.4
Bocanegra, R.5
Peters, J.I.6
Coalson, J.J.7
Graybill, J.R.8
Patterson, T.F.9
Williams III, R.O.10
-
106
-
-
34547782213
-
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient
-
Tong, S.Y., Peleg, A.Y., Yoong, J., Handke, R., Szer, J. & Slavin, M. (2007) Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transplant Infectious Diseases, 9, 241-243.
-
(2007)
Transplant Infectious Diseases
, vol.9
, pp. 241-243
-
-
Tong, S.Y.1
Peleg, A.Y.2
Yoong, J.3
Handke, R.4
Szer, J.5
Slavin, M.6
-
107
-
-
0023209654
-
Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies
-
Tricot, G., Joosten, E., Boogaerts, M.A., Vande Pitte, J. & Cauwenbergh, G. (1987) Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Reviews in Infectious Diseases, 9(Suppl 1), S94-S99.
-
(1987)
Reviews in Infectious Diseases
, vol.9
, Issue.SUPPL. 1
-
-
Tricot, G.1
Joosten, E.2
Boogaerts, M.A.3
Vande Pitte, J.4
Cauwenbergh, G.5
-
108
-
-
15544367832
-
Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice
-
Trifilio, S., Verma, A. & Mehta, J. (2004) Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplantation, 33, 735-739.
-
(2004)
Bone Marrow Transplantation
, vol.33
, pp. 735-739
-
-
Trifilio, S.1
Verma, A.2
Mehta, J.3
-
109
-
-
33846410666
-
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
-
Ullmann, A.J., Lipton, J.H., Vesole, D.H., Chandrasekar, P., Langston, A., Tarantolo, S.R., Greinix, H., de Azevedo, W.M., Reddy, V., Boparai, N., Pedicone, L., Patino, H. & Durrant, S. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. New England Journal of Medicine, 356, 335-347.
-
(2007)
New England Journal of Medicine
, vol.356
, pp. 335-347
-
-
Ullmann, A.J.1
Lipton, J.H.2
Vesole, D.H.3
Chandrasekar, P.4
Langston, A.5
Tarantolo, S.R.6
Greinix, H.7
de Azevedo, W.M.8
Reddy, V.9
Boparai, N.10
Pedicone, L.11
Patino, H.12
Durrant, S.13
-
110
-
-
33846934215
-
Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality
-
Upton, A., Kirby, K.A., Carpenter, P., Boeckh, M. & Marr, K.A. (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clinical Infectious Diseases, 44, 531-540.
-
(2007)
Clinical Infectious Diseases
, vol.44
, pp. 531-540
-
-
Upton, A.1
Kirby, K.A.2
Carpenter, P.3
Boeckh, M.4
Marr, K.A.5
-
111
-
-
0000109935
-
Amphotericin B toxicity
-
Utz, J.P., Bennett, J.E. & Bondriss, M.W. (1964) Amphotericin B toxicity. Annals of Internal Medicine, 61, 334-354.
-
(1964)
Annals of Internal Medicine
, vol.61
, pp. 334-354
-
-
Utz, J.P.1
Bennett, J.E.2
Bondriss, M.W.3
-
112
-
-
0015490690
-
Miconazole, a broad-spectrum antimycotic agent with antibacterial activity
-
Van Cutsem, J.M. & Thienpont, D. (1972) Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy, 17, 392-404.
-
(1972)
Chemotherapy
, vol.17
, pp. 392-404
-
-
Van Cutsem, J.M.1
Thienpont, D.2
-
113
-
-
27744597532
-
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials
-
Vardakas, K.Z., Michalopoulos, A. & Falagas, M.E. (2005) Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. British Journal of Haematology, 131, 22-28.
-
(2005)
British Journal of Haematology
, vol.131
, pp. 22-28
-
-
Vardakas, K.Z.1
Michalopoulos, A.2
Falagas, M.E.3
-
114
-
-
35448957762
-
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)
-
Vehreschild, J.J., Bohme, A., Bucheidt, D., Arenz, D., Harnisschmacher, U., Heussel, C.P., Ullmann, A.J., Mousset, S., Hummel, M., Frommolt, P., Wassmer, G., drzisga, I. & Cornely, O.A. (2007) A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). Journal of Infection, 55, 445-449.
-
(2007)
Journal of Infection
, vol.55
, pp. 445-449
-
-
Vehreschild, J.J.1
Bohme, A.2
Bucheidt, D.3
Arenz, D.4
Harnisschmacher, U.5
Heussel, C.P.6
Ullmann, A.J.7
Mousset, S.8
Hummel, M.9
Frommolt, P.10
Wassmer, G.11
drzisga, I.12
Cornely, O.A.13
-
115
-
-
69949181584
-
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry
-
Vehreschild, J.J., Sieniawski, M., Reuter, S., Arenz, D., Reichart, D., Maertens, J., Bohme, A., Silling, G., Martino, R., Maschmeyer, G., Ruping, M.J.G.T., Ullmann, A.J. & Cornely, O.A. (2009) Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry. International Journal of Antimicrobial Agents, 34, 446-450.
-
(2009)
International Journal of Antimicrobial Agents
, vol.34
, pp. 446-450
-
-
Vehreschild, J.J.1
Sieniawski, M.2
Reuter, S.3
Arenz, D.4
Reichart, D.5
Maertens, J.6
Bohme, A.7
Silling, G.8
Martino, R.9
Maschmeyer, G.10
Ruping, M.J.G.T.11
Ullmann, A.J.12
Cornely, O.A.13
-
116
-
-
77954187715
-
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6year experience of the Cologne AML cohort
-
Vehreschild, J.J., Ruping, M.J.G.T., Wisplinghoff, H., Farowski, F., Steinbach, A., Sims, R., Stollorz, A., Kreuzer, K.-A., Hallek, M., Bangard, C. & Cornely, O.A. (2010) Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6year experience of the Cologne AML cohort. Journal of Antimicrobial Chemotherapy, 65, 1466-1471.
-
(2010)
Journal of Antimicrobial Chemotherapy
, vol.65
, pp. 1466-1471
-
-
Vehreschild, J.J.1
Ruping, M.J.G.T.2
Wisplinghoff, H.3
Farowski, F.4
Steinbach, A.5
Sims, R.6
Stollorz, A.7
Kreuzer, K.-A.8
Hallek, M.9
Bangard, C.10
Cornely, O.A.11
-
117
-
-
33845710284
-
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
-
Walsh, T.J., Raad, I., Patterson, T.F., Chandrasekar, P., Donowitz, G.R., Graybill, R., Greene, R.E., Hachem, R., Hadley, S., Herbrecht, R., Langston, A., Louie, A., Ribaud, P., Segal, B.H., Stevens, D.A., van Burik, J.A., White, C.S., Corcoran, G., Gogate, J., Krishna, G., Pedicone, L., Hardalo, C. & Perfect, J.R. (2007) Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clinical Infectious Diseases, 44, 2-12.
-
(2007)
Clinical Infectious Diseases
, vol.44
, pp. 2-12
-
-
Walsh, T.J.1
Raad, I.2
Patterson, T.F.3
Chandrasekar, P.4
Donowitz, G.R.5
Graybill, R.6
Greene, R.E.7
Hachem, R.8
Hadley, S.9
Herbrecht, R.10
Langston, A.11
Louie, A.12
Ribaud, P.13
Segal, B.H.14
Stevens, D.A.15
van Burik, J.A.16
White, C.S.17
Corcoran, G.18
Gogate, J.19
Krishna, G.20
Pedicone, L.21
Hardalo, C.22
Perfect, J.R.23
more..
-
118
-
-
39449095735
-
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
-
Walsh, T.J., Anaissie, E.J., Denning, D.W., Herbrecht, R., Kontoyiannis, D.P., Marr, K.A., Morrison, V.A., Segal, B.H., Steinbach, W.J., Stevens, D.A., van Burik, J.-A., Wingard, J.R. & Patterson, T.F. (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases, 46, 327-360.
-
(2008)
Clinical Infectious Diseases
, vol.46
, pp. 327-360
-
-
Walsh, T.J.1
Anaissie, E.J.2
Denning, D.W.3
Herbrecht, R.4
Kontoyiannis, D.P.5
Marr, K.A.6
Morrison, V.A.7
Segal, B.H.8
Steinbach, W.J.9
Stevens, D.A.10
van Burik, J.-A.11
Wingard, J.R.12
Patterson, T.F.13
-
119
-
-
0023625187
-
Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole
-
Wingard, J.R., Vaughan, W.P., Braine, H.G., Merz, W.G. & Saral, R. (1987) Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. American Journal of Medicine, 83, 1103-1110.
-
(1987)
American Journal of Medicine
, vol.83
, pp. 1103-1110
-
-
Wingard, J.R.1
Vaughan, W.P.2
Braine, H.G.3
Merz, W.G.4
Saral, R.5
-
120
-
-
78650058029
-
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
-
Wingard, J.R., Carter, S.L., Walsh, T.J., Kurtzberg, J., Small, T.N., Baden, L.R., Gersten, I.D., Mendizabal, A.M., Leather, H.L., Confer, D.L., Maziarz, R.T., Stadtmauer, E.A., Bolanos-Meade, J., Brown, J., DiPersio, J.F., Boeckh, M. & Marr, K.A. (2010) Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood, 116, 5111-5118.
-
(2010)
Blood
, vol.116
, pp. 5111-5118
-
-
Wingard, J.R.1
Carter, S.L.2
Walsh, T.J.3
Kurtzberg, J.4
Small, T.N.5
Baden, L.R.6
Gersten, I.D.7
Mendizabal, A.M.8
Leather, H.L.9
Confer, D.L.10
Maziarz, R.T.11
Stadtmauer, E.A.12
Bolanos-Meade, J.13
Brown, J.14
DiPersio, J.F.15
Boeckh, M.16
Marr, K.A.17
-
121
-
-
0027394670
-
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial
-
Winston, D.J., Chandrasekar, P.H., Lazarus, H.M., Goodman, J.L., Silber, J.L., Horowitz, H., Shadduck, R.K., Rosenfeld, C.S., Ho, W.G., Islam, M.Z. & Buell, D.N. (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Annals of Internal Medicine, 118, 495-503.
-
(1993)
Annals of Internal Medicine
, vol.118
, pp. 495-503
-
-
Winston, D.J.1
Chandrasekar, P.H.2
Lazarus, H.M.3
Goodman, J.L.4
Silber, J.L.5
Horowitz, H.6
Shadduck, R.K.7
Rosenfeld, C.S.8
Ho, W.G.9
Islam, M.Z.10
Buell, D.N.11
-
122
-
-
0037736664
-
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial
-
Winston, D.J., Maziarz, R.T., Chandrasekar, P.H., Lazarus, H.M., Goldman, M., Blumer, J.L., Leitz, G.J. & Territo, M.C. (2003) Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Annals of Internal Medicine, 138, 705-713.
-
(2003)
Annals of Internal Medicine
, vol.138
, pp. 705-713
-
-
Winston, D.J.1
Maziarz, R.T.2
Chandrasekar, P.H.3
Lazarus, H.M.4
Goldman, M.5
Blumer, J.L.6
Leitz, G.J.7
Territo, M.C.8
-
123
-
-
79957574721
-
Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem-cell transplantation recipients
-
Winston, D.J., Bartoni, K., Territo, M.C. & Schiller, G.J. (2010) Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem-cell transplantation recipients. Biology of Blood and Marrow Transplantation, doi:
-
(2010)
Biology of Blood and Marrow Transplantation
-
-
Winston, D.J.1
Bartoni, K.2
Territo, M.C.3
Schiller, G.J.4
-
124
-
-
71449090672
-
Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients
-
Wirk, B. & Wingard, J.R. (2009) Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients. Mycopathologia, 168, 299-311.
-
(2009)
Mycopathologia
, vol.168
, pp. 299-311
-
-
Wirk, B.1
Wingard, J.R.2
|